EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-SA 4.0

Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old

Bahar Uncu Ulu, Tuğçe Nur Yiğenoğlu, Semih Başcı, Mehmet Bakırtaş, Derya Şahin, Tahir Darçın, Jale Yıldız, Alparslan Merdin, Nuran Ahu Baysal, Dicle İskender, Mehmet Sinan Dal, Merih Kızıl Çakar und 1 weitere

Medical Laboratory Technology Journal · 2021

DOI: 10.31964/mltj.v0i0.280 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Laboratory Technology Journal, 2021. Verfasst von Bahar Uncu Ulu und 12 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The incidence of Multiple myeloma (MM) increases with age; two-thirds of the patients are older than 65 years. Induction treatment, including new agents such as thalidomide, bortezomib, and lenalidomide followed by a conditioning regimen and upfront autologous stem cell transplantation (ASCT), has been accepted the standard treatment approach for newly diagnosed fit MM patients. We aimed to search the real-life data, the efficacy and safety of upfront ASCT following induction in patients with MM over 60 years old retrospectively. The data of MM patients who were ≥60 years old during autologous stem cell transplantation and treated at our center between 2010 and 2018 retrospectively analyzed. The study results were 63 patients included at the age of ≥ 60 years who underwent upfront ASCT. Median PFS was 15.5±2.6 months, and the median overall survival (OS) was 28.15±5 months. According to age groups, median PFS was 12±2.3 months in the 60-64 age group, 18.4±6 months in the 65-69 age group, and 26±15 months in the ≥70 age group. Median OS was 26.5±6.1 months in the 60-64 age group, 39.66±8.9 months in the 65-69 age group, and 18 months in the ≥70 age group. A significant relationship between the quantity of infused CD34+ stem cells and PFS and OS (p:0.05 and p

Zitieren

APA

Ulu, B. U., Yiğenoğlu, T. N., Başcı, S., Bakırtaş, M., Şahin, D., Darçın, T., Yıldız, J., Merdin, A., Baysal, N. A., İskender, D., Dal, M. S., Çakar, M. K., & Altuntaş, F. (2021). Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old. Medical Laboratory Technology Journal. https://doi.org/10.31964/mltj.v0i0.280

Vancouver

Ulu BU, Yiğenoğlu TN, Başcı S, Bakırtaş M, Şahin D, Darçın T, et al. Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old. Medical Laboratory Technology Journal. 2021. doi:10.31964/mltj.v0i0.280

BibTeX
@article{Ulu2021,
  author = {Ulu, Bahar Uncu and Yiğenoğlu, Tuğçe Nur and Başcı, Semih and Bakırtaş, Mehmet and Şahin, Derya and Darçın, Tahir and Yıldız, Jale and Merdin, Alparslan and Baysal, Nuran Ahu and İskender, Dicle and Dal, Mehmet Sinan and Çakar, Merih Kızıl and Altuntaş, Fevzi},
  title = {Autologous Stem Cell Transplantation in Multiple Myeloma Patients Over 60 Years Old},
  journal = {Medical Laboratory Technology Journal},
  year = {2021},
  doi = {10.31964/mltj.v0i0.280}
}
Kostenlos starten →